Loading…
“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care
Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2...
Saved in:
Published in: | Patient preference and adherence 2022-08, Vol.16, p.2031-2039 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3 |
---|---|
cites | cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3 |
container_end_page | 2039 |
container_issue | |
container_start_page | 2031 |
container_title | Patient preference and adherence |
container_volume | 16 |
creator | Matthes, Anni Wolf, Florian Bleidorn, Jutta Markwart, Robby |
description | Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility |
doi_str_mv | 10.2147/PPA.S372366 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A718217543</galeid><doaj_id>oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89</doaj_id><sourcerecordid>A718217543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</originalsourceid><addsrcrecordid>eNptkk2LEzEYxwdR3HX15BcICCLI1GQmk5eLUIqrhZUt23X1FjKZpE2ZTrpJZmVvvXv0ql-un8T0BdmKzCFD8svvefLnybKXCA4KhOm7yWQ4mJa0KAl5lJ0iRGnOGP_2-MH_SfYshAWEpCQFepqdlBWnFaLFafZjs_41juCrDOBG-3swckvjfLTdDEQHzm3XgMs-gis7m0cw_C7vB5v1b7BZ_wQTGa3uIphoH1ZaRXunA3AdmDjbxdyZfCS9Bp9dq1XfSg-mw6tpPnI3eQGuddhVsIn2dim3dRP8PHtiZBv0i8N6ln05_3A9-pRfXH4cj4YXucIMxpxKyUoCdYGVrEgNa8gNI1xzaHTNag4RJdDUNcbG8JKShmklMUSImAqxxpRn2XjvbZxciNW-A-GkFbsN52dCpghUqwVSBGPUMEwowZXmtZJF8rKmZpIYxpPr_d616uulblRKxMv2SHp80tm5mLk7kTqrOGdJ8OYg8O62T8GIpQ1Kt63stOuDKCgsMaIclwl99Q-6cL3vUlQ7CrGS7jo6UDOZHmA741JdtZWKIUWsQLTauQb_odLX6KVVrtPGpv2jC68fXJhr2cZ5cG0frevCMfh2DyrvQvDa_A0DQbEdWJEGVhwGtvwDcbHb5w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703183789</pqid></control><display><type>article</type><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><source>Publicly Available Content Database</source><source>Taylor & Francis Open Access Journals</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</creator><creatorcontrib>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</creatorcontrib><description>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</description><identifier>ISSN: 1177-889X</identifier><identifier>EISSN: 1177-889X</identifier><identifier>DOI: 10.2147/PPA.S372366</identifier><identifier>PMID: 35975172</identifier><language>eng</language><publisher>Auckland: Dove Medical Press Limited</publisher><subject>acceptance ; Analysis ; Antigens ; Coronaviruses ; COVID-19 ; Epidemics ; Family medicine ; feasibility ; Health aspects ; Health care ; Health insurance ; Infections ; Laboratories ; Medical research ; Medicine, Experimental ; Original Research ; Pandemics ; Patients ; Pediatrics ; Physicians ; poct ; Primary care ; Quarantine ; Questionnaires ; rapid test ; Severe acute respiratory syndrome coronavirus 2 ; Surveys ; Willingness to pay</subject><ispartof>Patient preference and adherence, 2022-08, Vol.16, p.2031-2039</ispartof><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Matthes et al. 2022 Matthes et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</citedby><cites>FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</cites><orcidid>0000-0003-1765-0344</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2703183789/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2703183789?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids></links><search><creatorcontrib>Matthes, Anni</creatorcontrib><creatorcontrib>Wolf, Florian</creatorcontrib><creatorcontrib>Bleidorn, Jutta</creatorcontrib><creatorcontrib>Markwart, Robby</creatorcontrib><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><title>Patient preference and adherence</title><description>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</description><subject>acceptance</subject><subject>Analysis</subject><subject>Antigens</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Epidemics</subject><subject>Family medicine</subject><subject>feasibility</subject><subject>Health aspects</subject><subject>Health care</subject><subject>Health insurance</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Physicians</subject><subject>poct</subject><subject>Primary care</subject><subject>Quarantine</subject><subject>Questionnaires</subject><subject>rapid test</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Surveys</subject><subject>Willingness to pay</subject><issn>1177-889X</issn><issn>1177-889X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk2LEzEYxwdR3HX15BcICCLI1GQmk5eLUIqrhZUt23X1FjKZpE2ZTrpJZmVvvXv0ql-un8T0BdmKzCFD8svvefLnybKXCA4KhOm7yWQ4mJa0KAl5lJ0iRGnOGP_2-MH_SfYshAWEpCQFepqdlBWnFaLFafZjs_41juCrDOBG-3swckvjfLTdDEQHzm3XgMs-gis7m0cw_C7vB5v1b7BZ_wQTGa3uIphoH1ZaRXunA3AdmDjbxdyZfCS9Bp9dq1XfSg-mw6tpPnI3eQGuddhVsIn2dim3dRP8PHtiZBv0i8N6ln05_3A9-pRfXH4cj4YXucIMxpxKyUoCdYGVrEgNa8gNI1xzaHTNag4RJdDUNcbG8JKShmklMUSImAqxxpRn2XjvbZxciNW-A-GkFbsN52dCpghUqwVSBGPUMEwowZXmtZJF8rKmZpIYxpPr_d616uulblRKxMv2SHp80tm5mLk7kTqrOGdJ8OYg8O62T8GIpQ1Kt63stOuDKCgsMaIclwl99Q-6cL3vUlQ7CrGS7jo6UDOZHmA741JdtZWKIUWsQLTauQb_odLX6KVVrtPGpv2jC68fXJhr2cZ5cG0frevCMfh2DyrvQvDa_A0DQbEdWJEGVhwGtvwDcbHb5w</recordid><startdate>20220831</startdate><enddate>20220831</enddate><creator>Matthes, Anni</creator><creator>Wolf, Florian</creator><creator>Bleidorn, Jutta</creator><creator>Markwart, Robby</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1765-0344</orcidid></search><sort><creationdate>20220831</creationdate><title>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</title><author>Matthes, Anni ; Wolf, Florian ; Bleidorn, Jutta ; Markwart, Robby</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>acceptance</topic><topic>Analysis</topic><topic>Antigens</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Epidemics</topic><topic>Family medicine</topic><topic>feasibility</topic><topic>Health aspects</topic><topic>Health care</topic><topic>Health insurance</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Physicians</topic><topic>poct</topic><topic>Primary care</topic><topic>Quarantine</topic><topic>Questionnaires</topic><topic>rapid test</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Surveys</topic><topic>Willingness to pay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matthes, Anni</creatorcontrib><creatorcontrib>Wolf, Florian</creatorcontrib><creatorcontrib>Bleidorn, Jutta</creatorcontrib><creatorcontrib>Markwart, Robby</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Patient preference and adherence</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matthes, Anni</au><au>Wolf, Florian</au><au>Bleidorn, Jutta</au><au>Markwart, Robby</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care</atitle><jtitle>Patient preference and adherence</jtitle><date>2022-08-31</date><risdate>2022</risdate><volume>16</volume><spage>2031</spage><epage>2039</epage><pages>2031-2039</pages><issn>1177-889X</issn><eissn>1177-889X</eissn><abstract>Background: The use of point-of-care tests (POCTs) has been a central strategy to cope with the COVID-19 pandemic. Yet, evidence on the application and consequences of POCTs within medical settings is rare. Purpose: To assess and understand patient perspectives on molecular point-of-care SARS-CoV-2 testing conducted in primary care. Methods: We conducted a cross-sectional survey study among patients who were tested with a molecular SARS-CoV-2 rapid test (ID NOW[TM] COVID-19 rapid test, Abbott) in 13 primary care practices in the state of Thuringia (Germany) from February to April 2021. The following aspects were covered in the questionnaire through rating scales and open text formats: test characteristics, trust in test result, consequences of immediate result, cost amount willing to pay and expectations in the future. Open text answers were categorized; quantitative data were analyzed using descriptive statistics and a Mann--Whitney U-test to reveal differences in cost contribution depending on the test result. Results: A total of 215 patients from nine family practices and one pediatric practice participated. The immediate availability of the test result was important to the majority of patients (94.3%). 95.7% of patients trusted in their test result. Personal consequences of the immediate test result referred to pandemic measures, certainty of action and reassurance. For further tests, patients were willing to pay between 0[euro] and 100[euro] (interquartile range = 10-25[euro]) for the molecular SARS-CoV-2 POCT, regardless of the test result. Expectations of being offered the test again in case of renewed cold symptoms were reported by 96.2%. Conclusion: Patients highly appreciated molecular SARS-CoV-2 rapid testing conducted in primary care practices. The immediate availability of the test result led to adjustments in patients' behavior and emotional wellbeing. However, potentially challenging for the implementation of POCTs in primary care practices may be the reimbursement of test costs and patients' expectations in future situation. Keywords: POCT, rapid test, COVID-19, acceptance, feasibility</abstract><cop>Auckland</cop><pub>Dove Medical Press Limited</pub><pmid>35975172</pmid><doi>10.2147/PPA.S372366</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1765-0344</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1177-889X |
ispartof | Patient preference and adherence, 2022-08, Vol.16, p.2031-2039 |
issn | 1177-889X 1177-889X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_1c6441d8467645e9bca244f8db8a6f89 |
source | Publicly Available Content Database; Taylor & Francis Open Access Journals; PubMed Central; Coronavirus Research Database |
subjects | acceptance Analysis Antigens Coronaviruses COVID-19 Epidemics Family medicine feasibility Health aspects Health care Health insurance Infections Laboratories Medical research Medicine, Experimental Original Research Pandemics Patients Pediatrics Physicians poct Primary care Quarantine Questionnaires rapid test Severe acute respiratory syndrome coronavirus 2 Surveys Willingness to pay |
title | “It Was Very Comforting to Find Out Right Away.” – Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CIt%20Was%20Very%20Comforting%20to%20Find%20Out%20Right%20Away.%E2%80%9D%20%E2%80%93%20Patient%20Perspectives%20on%20Point-of-Care%20Molecular%20SARS-CoV-2%20Testing%20in%20Primary%20Care&rft.jtitle=Patient%20preference%20and%20adherence&rft.au=Matthes,%20Anni&rft.date=2022-08-31&rft.volume=16&rft.spage=2031&rft.epage=2039&rft.pages=2031-2039&rft.issn=1177-889X&rft.eissn=1177-889X&rft_id=info:doi/10.2147/PPA.S372366&rft_dat=%3Cgale_doaj_%3EA718217543%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-7aa8360e24ca56b0b09f869e90feb8b901760fbb44ff9376d8eca40116f518df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2703183789&rft_id=info:pmid/35975172&rft_galeid=A718217543&rfr_iscdi=true |